alpha1at serine proteinase inhibitor protects lung degradation neutrophil proteases alpha1at deficiency autosomal recessive disorder resulting mutations alpha1at approved symbol serpina1 gene serum alpha1at levels NUMBER associated development emphysema virus aav serotype NUMBER aav2 vectors expressing alpha1at administered intramuscularly intravenously mediate sustained serum levels alpha1at experimental animals lung NUMBER body weight aav vector delivery muscle liver inefficient alpha1at does reach lung present study evaluates delivery human alpha1at halpha1at mice using intrapleural space platform local production alpha1at intrapleural administration vector achieves higher lung serum levels alpha1at intramuscular delivery serum lung alpha1at levels higher achieved aav2 delivery route diaphragm lung heart major sites transgene expression following intrapleural administration aav5 reporter vector NUMBER weeks postadministration intrapleural administration vector mediated serum alpha1at levels NUMBER NUMBER higher accepted therapeutic level NUMBER context pleura safe site administration intrapleural administration using aav5 vectors represent attractive gene therapy strategy alpha1at deficiency humans alpha1 antitrypsin adeno associated aav2 aav5 mediated aav5 halpha1at aav2 halpha1at aav5 mediated NUMBER fold aav5 halpha1at NUMBER fold microg ml c57bl NUMBER microg ml microg ml